Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-10
DOI
10.1186/s13046-019-1471-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability
- (2018) Hai Wang et al. CANCER CELL
- The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia
- (2016) H. Zhu et al. BLOOD
- Biomarker Tests for Molecularly Targeted Therapies: Laying the Foundation and Fulfilling the Dream
- (2016) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastric cancer
- (2016) Eric Van Cutsem et al. LANCET
- Epithelial calcineurin controls microbiota-dependent intestinal tumor development
- (2016) Kenneth Peuker et al. NATURE MEDICINE
- How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
- (2016) Simona Corso et al. TRENDS IN MOLECULAR MEDICINE
- Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53
- (2016) Wenping Ding et al. Scientific Reports
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RAG Represents a Widespread Threat to the Lymphocyte Genome
- (2015) Grace Teng et al. CELL
- Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17
- (2014) B Mojsa et al. CELL DEATH AND DIFFERENTIATION
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Oral Arsenic and Retinoic Acid for Non–High-Risk Acute Promyelocytic Leukemia
- (2014) Hong-Hu Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- NFAT Gene Family in Inflammation and Cancer
- (2013) M.-G. Pan et al. CURRENT MOLECULAR MEDICINE
- DNA damage signaling assessed in individual cells in relation to the cell cycle phase and induction of apoptosis
- (2012) Zbigniew Darzynkiewicz et al. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
- Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions
- (2012) Isabelle Soerjomataram et al. LANCET
- V(D)J Recombination: Mechanisms of Initiation
- (2011) David G. Schatz et al. Annual Review of Genetics
- PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
- (2010) Marion Jeanne et al. CANCER CELL
- The In Vivo Pattern of Binding of RAG1 and RAG2 to Antigen Receptor Loci
- (2010) Yanhong Ji et al. CELL
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- SnapShot: Ca2+-Calcineurin-NFATSignaling
- (2009) Gerald R. Crabtree et al. CELL
- A Non-Sequence-Specific DNA Binding Mode of RAG1 Is Inhibited by RAG2
- (2009) Shuying Zhao et al. JOURNAL OF MOLECULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started